Orphazyme names the last day of trading in US
![Photo: CARLO ALLEGRI/REUTERS / X02452](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13898734.ece/ALTERNATES/schema-16_9/doc7kg19w1ge6cv83dnh6p.jpg)
Danish biotech company Orphazyme, which is currently undergoing an in-court restructuring of its organization, reports that trading of its American Depositary Shares (ADSs) will terminate on July 6, a company press release has announced. Secondary trading of these assets ended last Friday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Orphazyme confirms delisting in the US
For subscribers
Orphazyme files for delisting in US
For subscribers